Predicting Grade of Cerebral Glioma Using Vascular-Space Occupancy MR Imaging

BACKGROUND AND PURPOSE: MR imaging can measure tissue perfusion and the integrity of the blood-brain barrier. We hypothesize that a combined measure of cerebral blood volume and vascular permeability using vascular-space occupancy (VASO) MR imaging, a recently developed imaging technique, is of diagnostic value for predicting tumor grade. MATERIALS AND METHODS: Thirty-nine patients (9 World Health Organization [WHO] grade II, 20 grade III, and 10 grade IV as determined by histopathologic assessment) were examined using VASO MR imaging, and regions-of-interest analysis was performed in tumoral regions, as well as in regions contralateral to the tumor. A Mann-Whitney test was conducted on the resulting VASO indices for a pairwise comparison across tumor grades. Nominal logistic regression was used to evaluate the use of VASO parameters for predicting group membership (by the percentage of correct classifications). RESULTS: The ratio between tumor side and contralateral side, VASORatio, showed significant differences in all 3 of the pairwise comparisons (P < .01). VASO values in the tumoral regions, VASOTumor, showed significant difference between grade II and III and between II and IV but not between III and IV. Both VASOTumor and VASORatio were found to be significant predictors of tumor grade, giving diagnostic accuracies of 66.7% and 71.8%, respectively. When testing to discriminate grade II tumors from higher grade tumors, the areas under the receiver operating characteristic curve were found to be 0.974 and 0.985 for VASOTumor and VASORatio, respectively. CONCLUSION: VASO MR imaging can be used for noninvasive tumor grade prediction based on cerebral blood volume and vascular permeability. VASO is more effective in separating WHO grade II from higher grades than in separating grade III from grade IV.

[1]  Michael F Gonzales,et al.  Grading of gliomas , 1997, Journal of Clinical Neuroscience.

[2]  Susan M. Chang,et al.  Age and the risk of anaplasia in magnetic resonance‐nonenhancing supratentorial cerebral tumors , 1997, Cancer.

[3]  Michael H Lev,et al.  Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. , 2004, AJNR. American journal of neuroradiology.

[4]  R. Sevick,et al.  How often are nonenhancing supratentorial gliomas malignant? A population study , 2002, Neurology.

[5]  M. Tomita Cerebral hyperemia and ischemia, from the standpoint of cerebral blood volume : proceedings of the statellite symposium, Brain Section, Fourth World Congress for Microcirculation, Osaka, Japan, 1-2 August 1987 , 1988 .

[6]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[7]  A Leviton,et al.  Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors , 2000, Cancer.

[8]  P. Burger,et al.  Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to treatment. , 1986, Seminars in oncology.

[9]  Glyn Johnson,et al.  Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.

[10]  Z L Gokaslan,et al.  Limitations of stereotactic biopsy in the initial management of gliomas. , 2001, Neuro-oncology.

[11]  O. Haraldseth,et al.  New intravascular contrast agent applied to dynamic contrast enhanced MR imaging of human breast cancer. , 2003, Acta radiologica.

[12]  Glyn Johnson,et al.  Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response. , 2006, Radiology.

[13]  W. Dillon,et al.  Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading. , 2002, Academic radiology.

[14]  M. Raichle,et al.  What is the Correct Value for the Brain-Blood Partition Coefficient for Water? , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  Raymond Sawaya,et al.  Extent of Resection in Malignant Gliomas: a Critical Summary , 2004, Journal of Neuro-Oncology.

[16]  Glyn Johnson,et al.  Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. , 2002, Radiology.

[17]  T. Poussaint,et al.  Advanced neuroimaging of pediatric brain tumors: MR diffusion, MR perfusion, and MR spectroscopy. , 2006, Neuroimaging clinics of North America.

[18]  M. Lev,et al.  Permeability versus cerebral blood volume measurement in brain tumor evaluation: comparative clinical value and advice to authors. , 2006, AJNR. American journal of neuroradiology.

[19]  Glyn Johnson,et al.  Novel approach to the measurement of absolute cerebral blood volume using vascular‐space‐occupancy magnetic resonance imaging , 2005, Magnetic resonance in medicine.

[20]  A. Sorensen,et al.  Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. , 2002, AJR. American journal of roentgenology.

[21]  L. K. Hansen,et al.  Defining a local arterial input function for perfusion MRI using independent component analysis , 2004, Magnetic resonance in medicine.

[22]  G Johnson,et al.  Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas. , 2006, AJNR. American journal of neuroradiology.

[23]  R. Sercombe,et al.  Neurophysiological Basis of Cerebral Blood Flow Control, An Introduction , 1995 .

[24]  Magalie Viallon,et al.  Quantification of myocardial blood flow and blood flow reserve in the presence of arterial dispersion: A simulation study , 2002, Magnetic resonance in medicine.

[25]  G Johnson,et al.  Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.

[26]  Glyn Johnson,et al.  Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. , 2004, AJNR. American journal of neuroradiology.

[27]  M Takahashi,et al.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. , 1998, AJR. American journal of roentgenology.

[28]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[29]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[30]  B. Rosen,et al.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results , 1996, Magnetic resonance in medicine.

[31]  D K Pearl,et al.  Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas , 1997, Cancer.

[32]  P. Kelly,et al.  Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.

[33]  K Scheffler,et al.  Analysis of input functions from different arterial branches with gamma variate functions and cluster analysis for quantitative blood volume measurements. , 2000, Magnetic resonance imaging.

[34]  E. Shaw,et al.  Prospective clinical trials of intracranial low-grade glioma in adults and children. , 2003, Neuro-oncology.

[35]  J. Pekar,et al.  Functional magnetic resonance imaging based on changes in vascular space occupancy , 2003, Magnetic resonance in medicine.